title: Role of HLA matching and pretransplant blood transfusions in cyclosporine-treated recipients of cadaveric renal allografts: 2- to 3-year results.
authors.affiliation: Huddinge Hospital, Stockholm, Sweden.
authors.forename: G
authors.initials: G
authors.lastname: Lundgren
authors.forename: D
authors.initials: D
authors.lastname: Albrechtsen
authors.forename: H
authors.initials: H
authors.lastname: Brynger
authors.forename: A
authors.initials: A
authors.lastname: Flatmark
authors.forename: L
authors.initials: L
authors.lastname: Frödin
authors.forename: H
authors.initials: H
authors.lastname: Gäbel
authors.forename: A
authors.initials: A
authors.lastname: Lindholm
authors.forename: W
authors.initials: W
authors.lastname: Maurer
authors.forename: E
authors.initials: E
authors.lastname: Möller
authors.forename: H
authors.initials: H
authors.lastname: Persson
mesh_terms: D001803:Blood Transfusion; D002102:Cadaver; D002986:Clinical Trials as Topic; D003524:Cyclosporins / Q000627:therapeutic use*; D006085:Graft Survival; D006681:HLA-D Antigens / Q000032:analysis*; D006684:HLA-DR Antigens / Q000032:analysis*; D006801:Humans; D007518:Isoantibodies / Q000032:analysis; D016030:Kidney Transplantation; D013601:T-Lymphocytes / Q000276:immunology
chemical_list: D003524:Cyclosporins; D006681:HLA-D Antigens; D006684:HLA-DR Antigens; D007518:Isoantibodies